Effects of the NMDA-receptor antagonist ketamine on perceptual correlates of long-term potentiation within the nociceptive system

We recently reported perceptual correlates of long-term potentiation (LTP) of synaptic strength within the nociceptive system demonstrating the functional relevance of LTP for human pain sensation. LTP is generally classified as NMDA-receptor dependent or independent. Here we show that low doses of the NMDA-receptor antagonist ketamine (0.25 mg/kg) prevented the long-term increase in perceived pain to electrical test stimuli, which was induced by high-frequency electrical stimulation (HFS) of nociceptive afferents. Whereas in a control experiment HFS led to a stable increase in perceived pain by 51% for the entire observation period of 1h HFS given 4 min after i.v. ketamine was ineffective. In contrast, HFS induced a two-fold increase of pinprick-evoked pain surrounding the HFS site (secondary neurogenic hyperalgesia) in both experiments. Pain evoked by light tactile stimuli (allodynia) was also unaffected by ketamine. These data support the concept that homotopic hyperalgesia to electrical stimulation of the conditioned pathway is a perceptual correlate of NMDA-receptor sensitive homosynaptic LTP in the nociceptive system, e.g. in the spinal cord. Although secondary neurogenic hyperalgesia and allodynia are induced by the same HFS protocol, they involve additional NMDA-receptor insensitive mechanisms of heterosynaptic facilitation.

[1]  W. Willis.  Long-term potentiation in spinothalamic neurons , 2002, Brain Research Reviews.

[2]  J. Sandkühler,et al.  Long-term potentiation of C-fiber-evoked potentials in the rat spinal dorsal horn is prevented by spinal N-methyl-d-aspartic acid receptor blockage , 1995, Neuroscience Letters.

[3]  C. Woolf,et al.  Central sensitization and LTP: do pain and memory share similar mechanisms? , 2003, Trends in Neurosciences.

[4]  R. Treede,et al.  Secondary hyperalgesia and perceptual wind-up following intradermal injection of capsaicin in humans , 1998, Pain.

[5]  F. Cerveró,et al.  One Pain or Many Pains , 1991 .

[6]  N. Hu,et al.  Activation of spinal d1/d5 receptors induces late-phase LTP of C-fiber-evoked field potentials in rat spinal dorsal horn. , 2005, Journal of neurophysiology.

[7]  D G Lambert,et al.  Ketamine: its mechanism(s) of action and unusual clinical uses. , 1996, British journal of anaesthesia.

[8]  W. Willis,et al.  Differential activation and classification of cutaneous afferents in the rat. , 1993, Journal of neurophysiology.

[9]  R. Treede,et al.  Modern Concepts of Pain and Hyperalgesia: Beyond the Polymodal C-Nociceptor , 1995 .

[10]  R. Gracely,et al.  Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects , 1995, PAIN®.

[11]  P. Eide,et al.  Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery , 1997, Acta anaesthesiologica Scandinavica.

[12]  F. Cerveró,et al.  Excitability changes of somatic and viscero‐somatic nociceptive reflexes in the decerebrate‐spinal rabbit: role of NMDA receptors. , 1995, The Journal of physiology.

[13]  R. Dubner,et al.  Activity‐induced plasticity in brain stem pain modulatory circuitry after inflammation , 2000, Neuroreport.

[14]  Jürgen Schüttler,et al.  A New Model of Electrically Evoked Pain and Hyperalgesia in Human Skin: The Effects of Intravenous Alfentanil, S (+)-ketamine, and Lidocaine , 2001, Anesthesiology.

[15]  E. Walters.  Injury-related behavior and neuronal plasticity: an evolutionary perspective on sensitization, hyperalgesia, and analgesia. , 1994, International review of neurobiology.

[16]  W. Willis,et al.  Role of calcitonin gene-related peptide in the sensitization of dorsal horn neurons to mechanical stimulation after intradermal injection of capsaicin. , 2004, Journal of neurophysiology.

[17]  A. Basbaum,et al.  The 5-HT3 Subtype of Serotonin Receptor Contributes to Nociceptive Processing via a Novel Subset of Myelinated and Unmyelinated Nociceptors , 2002, The Journal of Neuroscience.

[18]  P. Headley,et al.  Stimulus intensity, cell excitation and the N-methyl-d-aspartate receptor component of sensory responses in the rat spinal cord in vivo , 1997, Neuroscience.

[19]  J D Greenspan,et al.  Thresholds for the perception of pressure, sharpness, and mechanically evoked cutaneous pain: effects of laterality and repeated testing. , 1994, Somatosensory & motor research.

[20]  Hiroshi Ikeda,et al.  Synaptic Plasticity in Spinal Lamina I Projection Neurons That Mediate Hyperalgesia , 2003, Science.

[21]  Burton S. Rosner,et al.  Neuropharmacology , 1958, Nature.

[22]  M. Randić,et al.  Long-term potentiation and long-term depression of primary afferent neurotransmission in the rat spinal cord , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  T. Yaksh,et al.  Concentration‐Effect Relationships for Intravenous Alfentanil and Ketamine Infusions in Human Volunteers: Effects on Acute Thresholds and Capsaicin‐Evoked Hyperpathia , 2002, Journal of clinical pharmacology.

[24]  V. Lessmann,et al.  A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors. , 2003, Trends in pharmacological sciences.

[25]  C. Chavkin,et al.  Mu opiates inhibit long-term potentiation induction in the spinal cord slice. , 2001, Journal of neurophysiology.

[26]  K. Hole,et al.  AMPA and NMDA receptor‐dependent spinal LTP after nociceptive tetanic stimulation , 1998, Neuroreport.

[27]  A. Sollevi,et al.  The Synergistic Effect of Combined Treatment with Systemic Ketamine and Morphine on Experimentally Induced Windup-Like Pain in Humans , 2004, Anesthesia and analgesia.

[28]  J. Sandkühler,et al.  Low dose of S+-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivo. , 2005, British journal of anaesthesia.

[29]  J. Sandkühler,et al.  Characterization of long-term potentiation of C-fiber-evoked potentials in spinal dorsal horn of adult rat: essential role of NK1 and NK2 receptors. , 1997, Journal of neurophysiology.

[30]  C. Parsons,et al.  The N-methyl-d-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner , 2001, Neuroscience Letters.

[31]  E. Kandel,et al.  Is Heterosynaptic modulation essential for stabilizing hebbian plasiticity and memory , 2000, Nature Reviews Neuroscience.

[32]  J. Dahl,et al.  The effect of naloxone on ketamine-induced effects on hyperalgesia and ketamine-induced side effects in humans. , 1999, Anesthesiology.

[33]  S. Hunt,et al.  Role of central and peripheral tachykinin NK1 receptors in capsaicin-induced pain and hyperalgesia in mice , 2001, Pain.

[34]  M. Durieux,et al.  Ketamine: Teaching an Old Drug New Tricks , 1998, Anesthesia and analgesia.

[35]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[36]  W Paulus,et al.  Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. , 1997, Electroencephalography and clinical neurophysiology.

[37]  S. Hunt,et al.  Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways , 2002, Nature Neuroscience.

[38]  N. Hu,et al.  Diazepam inhibits the induction and maintenance of LTP of C-fiber evoked field potentials in spinal dorsal horn of rats , 2006, Neuropharmacology.

[39]  J. Sandkühler,et al.  Perceptual Correlates of Nociceptive Long-term Potentiation and Long-term Depression in Humans , 2003 .

[40]  R. Meyer,et al.  Roles of capsaicin-insensitive nociceptors in cutaneous pain and secondary hyperalgesia. , 2001, Brain : a journal of neurology.

[41]  Jürgen Sandkühler,et al.  Learning and memory in pain pathways , 2000, Pain.

[42]  J B Dahl,et al.  Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. , 1996, British journal of anaesthesia.

[43]  C. Parsons,et al.  NMDA receptors as targets for drug action in neuropathic pain. , 2001, European journal of pharmacology.

[44]  B. Bromm,et al.  Analgesic Efficacy of Low‐dose Ketamine: Somatosensory‐evoked Responses in Relation to Subjective Pain Ratings , 1996, Anesthesiology.